BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 18953259)

  • 1. Magnetic resonance imaging monitors physiological changes with antihedgehog therapy in pancreatic adenocarcinoma xenograft model.
    Guimaraes AR; Rakhlin E; Weissleder R; Thayer SP
    Pancreas; 2008 Nov; 37(4):440-4. PubMed ID: 18953259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin 35 Expression Correlates With Microvessel Density in Pancreatic Ductal Adenocarcinoma, Recruits Monocytes, and Promotes Growth and Angiogenesis of Xenograft Tumors in Mice.
    Huang C; Li Z; Li N; Li Y; Chang A; Zhao T; Wang X; Wang H; Gao S; Yang S; Hao J; Ren H
    Gastroenterology; 2018 Feb; 154(3):675-688. PubMed ID: 28989066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hedgehog signaling promotes angiogenesis directly and indirectly in pancreatic cancer.
    Bausch D; Fritz S; Bolm L; Wellner UF; Fernandez-Del-Castillo C; Warshaw AL; Thayer SP; Liss AS
    Angiogenesis; 2020 Aug; 23(3):479-492. PubMed ID: 32444947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiangiogenic tumor treatment: early noninvasive monitoring with USPIO-enhanced MR imaging in mice.
    Persigehl T; Bieker R; Matuszewski L; Wall A; Kessler T; Kooijman H; Meier N; Ebert W; Berdel WE; Heindel W; Mesters RM; Bremer C
    Radiology; 2007 Aug; 244(2):449-56. PubMed ID: 17562810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI with magnetic nanoparticles monitors downstream anti-angiogenic effects of mTOR inhibition.
    Guimaraes AR; Ross R; Figuereido JL; Waterman P; Weissleder R
    Mol Imaging Biol; 2011 Apr; 13(2):314-20. PubMed ID: 20559742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sonic hedgehog derived from human pancreatic cancer cells augments angiogenic function of endothelial progenitor cells.
    Yamazaki M; Nakamura K; Mizukami Y; Ii M; Sasajima J; Sugiyama Y; Nishikawa T; Nakano Y; Yanagawa N; Sato K; Maemoto A; Tanno S; Okumura T; Karasaki H; Kono T; Fujiya M; Ashida T; Chung DC; Kohgo Y
    Cancer Sci; 2008 Jun; 99(6):1131-8. PubMed ID: 18422746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hedgehog promotes neovascularization in pancreatic cancers by regulating Ang-1 and IGF-1 expression in bone-marrow derived pro-angiogenic cells.
    Nakamura K; Sasajima J; Mizukami Y; Sugiyama Y; Yamazaki M; Fujii R; Kawamoto T; Koizumi K; Sato K; Fujiya M; Sasaki K; Tanno S; Okumura T; Shimizu N; Kawabe J; Karasaki H; Kono T; Ii M; Bardeesy N; Chung DC; Kohgo Y
    PLoS One; 2010 Jan; 5(1):e8824. PubMed ID: 20098680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow-derived proangiogenic cells in pancreatic cancer.
    Mizukami Y
    J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2():23-6. PubMed ID: 22320912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of pre-clinical and clinical studies targeting angiogenesis in pancreatic ductal adenocarcinoma.
    Craven KE; Gore J; Korc M
    Cancer Lett; 2016 Oct; 381(1):201-10. PubMed ID: 26723874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor effects of EMAP II against pancreatic cancer through inhibition of fibronectin-dependent proliferation.
    Schwarz RE; Awasthi N; Konduri S; Caldwell L; Cafasso D; Schwarz MA
    Cancer Biol Ther; 2010 Apr; 9(8):632-9. PubMed ID: 20212356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of antiangiogenic treatment efficacy by iron oxide enhanced parametric magnetic resonance imaging.
    Persigehl T; Matuszewski L; Kessler T; Wall A; Meier N; Ebert W; Berdel WE; Heindel W; Mesters R; Bremer C
    Invest Radiol; 2007 Dec; 42(12):791-6. PubMed ID: 18007150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral Squamous Cell Carcinoma-derived Sonic Hedgehog Promotes Angiogenesis.
    Kuroda H; Kurio N; Shimo T; Matsumoto K; Masui M; Takabatake K; Okui T; Ibaragi S; Kunisada Y; Obata K; Yoshioka N; Kishimoto K; Nagatsuka H; Sasaki A
    Anticancer Res; 2017 Dec; 37(12):6731-6737. PubMed ID: 29187450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nestin as a novel therapeutic target for pancreatic cancer via tumor angiogenesis.
    Yamahatsu K; Matsuda Y; Ishiwata T; Uchida E; Naito Z
    Int J Oncol; 2012 May; 40(5):1345-57. PubMed ID: 22246533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the Hedgehog pathway induces autophagy in pancreatic ductal adenocarcinoma cells.
    Xu Y; An Y; Wang X; Zha W; Li X
    Oncol Rep; 2014 Feb; 31(2):707-12. PubMed ID: 24297612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VEGF and Id-1 in pancreatic adenocarcinoma: prognostic significance and impact on angiogenesis.
    Georgiadou D; Sergentanis TN; Sakellariou S; Filippakis GM; Zagouri F; Vlachodimitropoulos D; Psaltopoulou T; Lazaris AC; Patsouris E; Zografos GC
    Eur J Surg Oncol; 2014 Oct; 40(10):1331-7. PubMed ID: 24480377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer.
    Olive KP; Jacobetz MA; Davidson CJ; Gopinathan A; McIntyre D; Honess D; Madhu B; Goldgraben MA; Caldwell ME; Allard D; Frese KK; Denicola G; Feig C; Combs C; Winter SP; Ireland-Zecchini H; Reichelt S; Howat WJ; Chang A; Dhara M; Wang L; Rückert F; Grützmann R; Pilarsky C; Izeradjene K; Hingorani SR; Huang P; Davies SE; Plunkett W; Egorin M; Hruban RH; Whitebread N; McGovern K; Adams J; Iacobuzio-Donahue C; Griffiths J; Tuveson DA
    Science; 2009 Jun; 324(5933):1457-61. PubMed ID: 19460966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of sonic hedgehog signal pathway enhances antiproliferative effect of EGFR inhibitor in pancreatic cancer cells.
    Hu WG; Liu T; Xiong JX; Wang CY
    Acta Pharmacol Sin; 2007 Aug; 28(8):1224-30. PubMed ID: 17640486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring of bevacizumab-induced antiangiogenic treatment effects by "steady state" ultrasmall superparamagnetic iron oxide particles magnetic resonance imaging using robust multiecho ΔR2* relaxometry.
    Ring J; Persigehl T; Remmele S; Heindel W; Dahnke H; Bremer C
    Invest Radiol; 2011 May; 46(5):326-30. PubMed ID: 21358548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EMAP II-based antiangiogenic-antiendothelial in vivo combination therapy of pancreatic cancer.
    Schwarz RE; Awasthi N; Konduri S; Cafasso D; Schwarz MA
    Ann Surg Oncol; 2010 May; 17(5):1442-52. PubMed ID: 20041350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor Priming by SMO Inhibition Enhances Antibody Delivery and Efficacy in a Pancreatic Ductal Adenocarcinoma Model.
    Wang J; Chan DKW; Sen A; Ma WW; Straubinger RM
    Mol Cancer Ther; 2019 Nov; 18(11):2074-2084. PubMed ID: 31363010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.